Sociedad Americana de Hirudoterapia

Leech Therapy in the Head and Neck

Case series/review published in J Oral Maxillofac Surg (2025)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosSeguridad y control de infeccionesMoen G, Dillon J · Journal of oral and maxillofacial surgery, 2025

Abstract

BACKGROUND: Leech therapy has been used in medicine since ancient times for varying indications. More recently, it has come back into favor for treating venous congestion of surgical sites; however, there is limited data on the number of leeches and application techniques for the head and neck region compared with other anatomical subsites. PURPOSE: This study's purpose was to assess the response to leech therapy in a series of patients with venous congestion, review the literature to determine association between leech therapy use and venous congestion, and provide guidelines for leech therapy for use in the head and neck region. STUDY DESIGN: A retrospective case series of patients treated by the Department of Oral and Maxillofacial Surgery for venous congestion with leech therapy at Harborview Medical Center, Seattle, WA, was analyzed from 2016 to 2019. All nonleech cases were excluded. Literature review articles were gathered from PubMed and Scopus using the search terms leeching and venous congestion using the Boolean operator and. MAIN OUTCOME VARIABLE: The main outcome variable in this study was tissue loss in reconstructive sites of the head and neck, defined as no tissue loss, partial tissue loss, or complete loss of tissue. COVARIATES: Covariates included age, gender, medical comorbidities, type of operation required, and chief complaint. Number of leeches used, duration, and antibiotic prophylaxis agents were also gathered. Data gathered from articles included in the literature review included study design, population, number of leeches used, duration, complications, and amount of tissue lost or salvaged. ANALYSES: Descriptive statistics were calculated for data gathered from patient cases. RESULTS: Seven cases were reviewed with a mean age of 60.86 years. Five (71%) subjects experienced venous congestion resulting from resection or reconstruction of malignancy and 2 (29%) after laceration repair. Three subjects (43%) had complete recovery from venous congestion following leech therapy. Four subjects (57%) had partial (minor) tissue loss secondary to necrosis. No subject had complete loss of tissue. From the article review, 16 articles were identified, consisting of 3 systematic reviews, one literature review, and 13 retrospective case series ranging from 6 to 277 cases. CONCLUSIONS AND RELEVANCE: Leech therapy is a viable treatment option for venous congestion. Patients should be screened for coagulopathy, use of blood thinners, and psychological acceptance to therapy prior to initiating leech therapy; antibiotic prophylaxis is essential for preventing infection with Aeromonas hydrophila.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsHumansLeechingRetrospective StudiesMaleFemaleMiddle AgedAgedHyperemiaAdultHeadNeckTreatment Outcome

Resumen

Retrospective case series of 7 head and neck venous congestion patients with leech therapy: 43% complete recovery, 57% partial tissue loss, no complete loss. Literature review of 16 articles.

Por qué esto importa para la hirudoterapia

Esta serie de casos retrospectiva analizó siete pacientes (edad media 60,86 años) tratados con terapia de sanguijuelas por congestión venosa en sitios reconstructivos de cabeza y cuello en una institución entre 2016 y 2019, complementada con una revisión de la literatura de 16 artículos. Tres sujetos (43%) presentaron recuperación completa y cuatro (57%) presentaron pérdida tisular menor parcial por necrosis; ningún sujeto presentó pérdida tisular completa. El estudio proporciona orientación práctica que incluye el cribado de coagulopatía, anticoagulantes y aceptación psicológica, y enfatiza la profilaxis antibiótica contra Aeromonas hydrophila. Esto es directamente relevante para el dominio de ASH. La salvedad es la pequeña muestra institucional única de siete casos, y el componente de revisión de la literatura se basa en series de casos retrospectivas.

Citación

Leech Therapy in the Head and Neck.

Moen G, Dillon J · Journal of oral and maxillofacial surgery, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.